Regression of choroidal neovascularization in response to systemic chemotherapy for cancer.
Annie W
AW
Hsu
Akrit
A
Sodhi
Charles
C
Eberhart
Silvia
S
Montaner
Morton F
MF
Goldberg
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy* / Q000473:pathology; D020256:Choroidal Neovascularization / Q000188:drug therapy* / Q000503:physiopathology; D002945:Cisplatin / Q000008:administration & dosage; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives; D000077143:Docetaxel; D017809:Fatal Outcome; D005451:Fluorescein Angiography; D006801:Humans; D008297:Male; D012074:Remission Induction; D043823:Taxoids / Q000008:administration & dosage; D041623:Tomography, Optical Coherence; D014523:Urethral Neoplasms / Q000188:drug therapy* / Q000473:pathology; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000473:pathology; D000093542:Gemcitabine
D043823:Taxoids; D003841:Deoxycytidine; D000077143:Docetaxel; D002945:Cisplatin; D000093542:Gemcitabine